{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T19:57:16Z","timestamp":1780775836767,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77945-y","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T07:36:44Z","timestamp":1731310604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis for type of 53BP1 nuclear expression by immunofluorescence as an indicator of genomic instability in oropharyngeal squamous epithelial lesions"],"prefix":"10.1038","volume":"14","author":[{"given":"Hideaki","family":"Nishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Terakado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisayoshi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Kumai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"77945_CR1","volume-title":"Report of Head and Neck Cancer Registry of Japan Clinical Statistics of Registered Patients","year":"2023","unstructured":"Nibu, K.-I. et al. (eds) Report of Head and Neck Cancer Registry of Japan Clinical Statistics of Registered Patients (Japan Society for Head and Neck Cancer, 2023)."},{"key":"77945_CR2","volume-title":"WHO Classification of Head and Neck Tumours","author":"AK El-Naggar","year":"2017","unstructured":"El-Naggar, A. K., Chan, J. K. C., Grandis, K. R., Takata, T. & Slootweg, P. WHO Classification of Head and Neck Tumours 4th edn. (IARC Press, 2017).","edition":"4"},{"key":"77945_CR3","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/ijc.28142","volume":"133","author":"D Holzinger","year":"2013","unstructured":"Holzinger, D. et al. Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway. Int. J. Cancer 133, 1389\u20131399 (2013).","journal-title":"Int. J. Cancer"},{"issue":"Suppl 1","key":"77945_CR4","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1007\/s12105-012-0371-6","volume":"6","author":"WH Westra","year":"2012","unstructured":"Westra, W. H. The morphologic profile of HPV-related head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management. Head Neck Pathol. 6(Suppl 1), S48-54 (2012).","journal-title":"Head Neck Pathol."},{"key":"77945_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jasc.2015.12.001","volume":"5","author":"DB Allison","year":"2016","unstructured":"Allison, D. B. & Maleki, Z. HPV-related head and neck squamous cell carcinoma: An update and review. J. Am. Soc. Cytopathol. 5, 203\u2013215 (2016).","journal-title":"J. Am. Soc. Cytopathol."},{"key":"77945_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/603740","volume":"2011","author":"T Tanaka","year":"2011","unstructured":"Tanaka, T. & Ishigamori, R. Understanding carcinogenesis for fighting oral cancer. J. Oncol. 2011, 603740 (2011).","journal-title":"J. Oncol."},{"key":"77945_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang, K. K. et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 363, 24\u201335 (2010).","journal-title":"N. Engl. J. Med."},{"key":"77945_CR8","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1083\/jcb.151.7.1381","volume":"151","author":"LB Schultz","year":"2000","unstructured":"Schultz, L. B., Chehab, N. H., Malikzay, A. & Halazonetis, T. D. P53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J. Cell Biol. 151, 1381\u20131390 (2000).","journal-title":"J. Cell Biol."},{"key":"77945_CR9","first-page":"936","volume":"63","author":"K Suzuki","year":"2003","unstructured":"Suzuki, K., Yokoyama, S., Waseda, S., Kodama, S. & Watanabe, M. Delayed reactivation of p53 in the progeny of cells surviving ionizing radiation. Cancer Res. 63, 936\u2013941 (2003).","journal-title":"Cancer Res."},{"key":"77945_CR10","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.molcel.2009.06.037","volume":"35","author":"L Cao","year":"2009","unstructured":"Cao, L. et al. A selective requirement for 53BP1 in the biological response to genomic instability induced by BRCA1 deficiency. Mol. Cell 35, 534\u2013541 (2009).","journal-title":"Mol. Cell"},{"key":"77945_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2010.03.012","volume":"141","author":"SF Bunting","year":"2010","unstructured":"Bunting, S. F. et al. 53BP1 inhibits homologous recombination in BRCA1-deficient cells by blocking resection of DNA breaks. Cell 141, 243\u2013254 (2010).","journal-title":"Cell"},{"key":"77945_CR12","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nsmb.1831","volume":"17","author":"P Bouwman","year":"2010","unstructured":"Bouwman, P. et al. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat. Struct. Mol. Biol. 17, 688\u2013695 (2010).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"77945_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.molcel.2012.02.015","volume":"46","author":"SF Bunting","year":"2012","unstructured":"Bunting, S. F. et al. BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair. Mol. Cell 46, 125\u2013135 (2012).","journal-title":"Mol. Cell"},{"key":"77945_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/25292","volume":"396","author":"C Lengauer","year":"1998","unstructured":"Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643\u2013649. https:\/\/doi.org\/10.1038\/25292 (1998).","journal-title":"Nature"},{"key":"77945_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/s0092-8674(02)00770-5","volume":"109","author":"C Zhu","year":"2002","unstructured":"Zhu, C. et al. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 109, 811\u2013821. https:\/\/doi.org\/10.1016\/s0092-8674(02)00770-5 (2002).","journal-title":"Cell"},{"key":"77945_CR16","first-page":"4645","volume":"19","author":"WB Coleman","year":"1999","unstructured":"Coleman, W. B. & Tsongalis, G. J. The role of genomic instability in human carcinogenesis. Anticancer Res. 19, 4645\u20134664 (1999).","journal-title":"Anticancer Res."},{"key":"77945_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrm2858","volume":"11","author":"S Negrini","year":"2010","unstructured":"Negrini, S., Gorgoulis, V. G. & Halazonetis, T. D. Genomic instability\u2014an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 11, 220\u2013228. https:\/\/doi.org\/10.1038\/nrm2858 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"77945_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1365-2559.2011.03963.x","volume":"59","author":"K Matsuda","year":"2011","unstructured":"Matsuda, K. et al. Significance of p53-binding protein 1 nuclear foci in uterine cervical lesions: Endogenous DNA double strand breaks and genomic instability during carcinogenesis. Histopathology 59, 441\u2013451 (2011).","journal-title":"Histopathology"},{"key":"77945_CR19","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/ijc.23223","volume":"122","author":"M Nakashima","year":"2008","unstructured":"Nakashima, M. et al. Foci formation of P53-binding protein 1 in thyroid tumors: activation of genomic instability during thyroid carcinogenesis. Int. J. Cancer 122, 1082\u20131088 (2008).","journal-title":"Int. J. Cancer"},{"key":"77945_CR20","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/j.1349-7006.2008.00786.x","volume":"99","author":"Y Naruke","year":"2008","unstructured":"Naruke, Y. et al. Alteration of p53-binding protein 1 expression during skin carcinogenesis: association with genomic instability. Cancer Sci. 99, 946\u2013951 (2008).","journal-title":"Cancer Sci."},{"key":"77945_CR21","doi-asserted-by":"publisher","first-page":"15477","DOI":"10.1038\/s41598-018-33761-9","volume":"8","author":"K Matsuda","year":"2018","unstructured":"Matsuda, K. et al. Expression pattern of p53-binding protein 1 as a new molecular indicator of genomic instability in bladder urothelial carcinoma. Sci. Rep. 8, 15477 (2018).","journal-title":"Sci. Rep."},{"key":"77945_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1089\/thy.2018.0548","volume":"29","author":"R Otsubo","year":"2019","unstructured":"Otsubo, R. et al. A novel diagnostic method for thyroid follicular tumors based on immunofluorescence analysis of p53-binding protein 1 expression: detection of genomic instability. Thyroid 29, 657\u2013665 (2019).","journal-title":"Thyroid"},{"key":"77945_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152601","volume":"215","author":"N Ueki","year":"2019","unstructured":"Ueki, N. et al. Significant association between 53 BP1 expression and grade of intraepithelial neoplasia of esophagus: alteration during esophageal carcinogenesis. Pathol. Res. Pract. 215, 152601 (2019).","journal-title":"Pathol. Res. Pract."},{"key":"77945_CR24","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.21873\/anticanres.15292","volume":"41","author":"T Imaizumi","year":"2021","unstructured":"Imaizumi, T. et al. Detection of endogenous DNA double-strand breaks in oral squamous epithelial lesions by P53-binding protein 1. Anticancer Res. 41, 4771\u20134779 (2021).","journal-title":"Anticancer Res."},{"key":"77945_CR25","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1038\/s41598-021-82867-0","volume":"11","author":"TMH Luong","year":"2021","unstructured":"Luong, T. M. H. et al. Significance of abnormal 53BP1 expression as a novel molecular pathologic parameter of follicular-shaped B-cell lymphoid lesions in human digestive tract. Sci. Rep. 11, 3074 (2021).","journal-title":"Sci. Rep."},{"issue":"15","key":"77945_CR26","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.3390\/cancers14153577","volume":"14","author":"M Ueda","year":"2022","unstructured":"Ueda, M. et al. Molecular pathological characteristics of thyroid follicular-patterned tumors showing nodule-in-nodule appearance with poorly differentiated component. Cancers (Basel). 14(15), 3577. https:\/\/doi.org\/10.3390\/cancers14153577 (2022).","journal-title":"Cancers (Basel)."},{"key":"77945_CR27","volume-title":"AJCC Cancer Staging Manual","year":"2017","unstructured":"Amin, M. B. et al. et al. (eds) AJCC Cancer Staging Manual 8th edn. (Springer International Publishing, 2017).","edition":"8"},{"key":"77945_CR28","doi-asserted-by":"crossref","unstructured":"Gillison, M. L. et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92, 709\u2013720\u2013203074 (2000).","DOI":"10.1093\/jnci\/92.9.709"},{"key":"77945_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105620","volume":"123","author":"P Golusinski","year":"2021","unstructured":"Golusinski, P. et al. De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?. Oral Oncol. 123, 105620 (2021).","journal-title":"Oral Oncol."},{"key":"77945_CR30","doi-asserted-by":"crossref","unstructured":"Fortini, P., Ferretti, C. & Dogliotti, E. The response to DNA damage during differentiation: pathways and consequences. Mutat. Res. 743\u2013744, 160\u2013168 (2013).","DOI":"10.1016\/j.mrfmmm.2013.03.004"},{"key":"77945_CR31","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.1016\/j.jmb.2013.04.013","volume":"425","author":"C Trovesi","year":"2013","unstructured":"Trovesi, C., Manfrini, N., Falcettoni, M. & Longhese, M. P. Regulation of the DNA damage response by cyclin-dependent kinases. J. Mol. Biol. 425, 4756\u20134766 (2013).","journal-title":"J. Mol. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77945-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77945-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77945-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T12:14:21Z","timestamp":1731672861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77945-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77945"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77945-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"26 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed retrospectively in accordance with the tenets of the Declaration of Helsinki. The Ethics Committee of Nagasaki university hospital approved the study (approval date: November 20, 2018; #18111921) and waived the need for informed consent. All methods were carried out in accordance with relevant guidelines and regulations. Patient profiles were anonymized by coding and collectively summarized with the obtained data as the final dataset. Patients were able to opt out of the study by following the instructions provided on the institute website.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics committee approval and informed consent"}}],"article-number":"27525"}}